Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raab

Showing results (231-240 of 427) with videos related to

Pageof 43
Sort By:
Histochemistry and Cell Biology|December 17, 2015
Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease modelsJ Funk, V Ott, A Herrmann, et al.
American Journal of Hematology|April 25, 2025
Elotuzumab in Combination With Dose Reduced IMiDs and Dexamethasone for AL Amyloidosis Patients With Relapsed/Refractory Plasma Cell Dyscrasia and Advanced Organ InvolvementTobias Dittrich, Timon Hansen, Christoph R Kimmich, et al.
Hematological Oncology|March 19, 2015
Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow functionIris Breitkreutz, Natalia Becker, Axel Benner, et al.
Haematologica|November 4, 2006
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failureMarc S Raab, Iris Breitkreutz, Michael Hundemer, et al.
Cancer|April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasoneUlrike Klein, Anna Jauch, Thomas Hielscher, et al.
British Journal of Haematology|August 8, 2019
Development and validation of a novel risk stratification algorithm for relapsed multiple myelomaRoman Hájek, Michel Delforge, Marc S Raab, et al.
British Journal of Haematology|September 15, 2007
Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myelomaIris Breitkreutz, Marc S Raab, Sonia Vallet, et al.
British Journal of Pharmacology|March 16, 2013
Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 releaseC Ullmer, R Alvarez Sanchez, U Sprecher, et al.
Bone Marrow Transplantation|May 13, 2026
Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myelomaLeo Rasche, Maria Theresa Krauth, Hermine Agis, et al.
American Journal of Clinical Pathology|July 8, 2000
Effect of clinical history on diagnostic accuracy in the cytologic interpretation of bronchial brush specimensS S Raab, T Oweity, J H Hughes, et al.
Pageof 43

Showing results (231-240 of 427) with videos related to

Sort By:
Pageof 43
Histochemistry and Cell Biology|December 17, 2015
Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease modelsJ Funk, V Ott, A Herrmann, et al.
American Journal of Hematology|April 25, 2025
Elotuzumab in Combination With Dose Reduced IMiDs and Dexamethasone for AL Amyloidosis Patients With Relapsed/Refractory Plasma Cell Dyscrasia and Advanced Organ InvolvementTobias Dittrich, Timon Hansen, Christoph R Kimmich, et al.
Hematological Oncology|March 19, 2015
Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow functionIris Breitkreutz, Natalia Becker, Axel Benner, et al.
Haematologica|November 4, 2006
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failureMarc S Raab, Iris Breitkreutz, Michael Hundemer, et al.
Cancer|April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasoneUlrike Klein, Anna Jauch, Thomas Hielscher, et al.
British Journal of Haematology|August 8, 2019
Development and validation of a novel risk stratification algorithm for relapsed multiple myelomaRoman Hájek, Michel Delforge, Marc S Raab, et al.
British Journal of Haematology|September 15, 2007
Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myelomaIris Breitkreutz, Marc S Raab, Sonia Vallet, et al.
British Journal of Pharmacology|March 16, 2013
Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 releaseC Ullmer, R Alvarez Sanchez, U Sprecher, et al.
Bone Marrow Transplantation|May 13, 2026
Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myelomaLeo Rasche, Maria Theresa Krauth, Hermine Agis, et al.
American Journal of Clinical Pathology|July 8, 2000
Effect of clinical history on diagnostic accuracy in the cytologic interpretation of bronchial brush specimensS S Raab, T Oweity, J H Hughes, et al.
Pageof 43